Berlin, Germany
MAYD offers an innovative solution in the healthcare logistics sector with its promise: "Your meds delivered in 30 minutes, 365 days a year." Founded in 2021, the company aims to reshape healthcare access across Europe by providing efficient delivery of over 5,000 healthcare-related products. This ambitious goal is underpinned by significant backing from world-class investors, as demonstrated by their recent $34.00M Series A investment on 01 January 2022.
MAYD's operations are based in Germany and operate at the intersection of Health Care, Pharmaceutical, and Logistics and Delivery industries. The startup has drawn investments from reputable names such as Target Global, Lightspeed Venture Partners, Earlybird, and 468 Capital. Their team is lauded for including serial entrepreneurs and experienced operators committed to enhancing medication accessibility and timeliness.
MAYD's compelling value proposition and rapid traction in a critical market space make it an attractive consideration for investors keen on transformative healthcare innovations.
HomeGP.asia